JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Tyrphostin AG 1296 (AG-1296) is a novel, potent, selective and ATP-competitive inhibitor of PDGFR with potential antitumor activity. It inhibits PDGFR with IC50 of 0.3-0.5 uM, it has no activity against EGFR. Tyrphostin AG 1296 acts by binding to PDGFR, which causes a conformational change at the ATP-binding site. In an in vitro assay, it potently inhibits the ligand-induced autophosphorylation of PDGF receptor in Swiss 3T3 cell membranes. Tyrphostin AG 1296 does not affect the EGF receptor when the concentration is up to 100uM. Tyrphostin AG 1296 also inhibits the mitogenesis induced by PDGF but not EGF or insulin. It reversibly inhibits PDGF-induced DNA synthesis with a mean IC50 value of 1.5uM.
References: Cancer Res. 1994 Dec 1; 54(23):6106-14; Biochemistry. 1997 May 27; 36(21):6260-9.
Chemical Name: 2-Phenyl-6, 7-dimethoxyquinoxaline ; 6, 7-Dimethoxy-2-phenylquinoxaline
InChi Key: QNOXYUNHIGOWNY-UHFFFAOYSA-N
InChi Code: InChI=1S/C16H14N2O2/c1-19-15-8-12-13(9-16(15)20-2)18-14(10-17-12)11-6-4-3-5-7-11/h3-10H, 1-2H3
SMILES Code: COC1=C(OC)C=C2N=CC(C3=CC=CC=C3)=NC2=C1
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Recommend by mail
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!